Drug:
Reaction: INFLUENZA
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25491920 |
US |
2 | |
Influenza, Lactose intolerance, Rash pruritic, Product dose omission in error, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DALFAMPRIDINE, CHLORTHALIDONE, LOSARTAN POTASSIUM, LOSARTAN, FUROSEMIDE, |
||||
2 | 25492233 |
GB |
57 | 2 |
Influenza, Malaise, Hypokinesia, Pain, Poor quality sleep, Dyspnoea, Hot flush, Weight decreased, Anaemia, Urticaria, Rash, |
||||
USTEKINUMAB, VEDOLIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
3 | 25492517 |
US |
2 | |
Influenza, Pain, Arthralgia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LURASIDONE HYDROCHLORIDE, |
||||
4 | 25492732 |
US |
54 | 1 |
Influenza, Oxygen saturation decreased, |
||||
LANTHANUM CARBONATE, |
||||
5 | 25493316 |
US |
1 | |
Feeling abnormal, Influenza, |
||||
TIRZEPATIDE, |
||||
6 | 25494266 |
AR |
9 | 1 |
Bacterial infection, Influenza, Pneumonia, |
||||
NUSINERSEN, |
||||
7 | 25494676 |
CA |
||
Dysgeusia, Chills, Diarrhoea, Hypoglycaemia, Fatigue, Influenza, Diverticulitis, Nausea, Vomiting, Headache, Injection site rash, Injection site pruritus, Injection site erythema, Weight decreased, Intentional dose omission, Inappropriate schedule of product administration, Therapy partial responder, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, HYDROXYCHLOROQUINE SULFATE, CLONAZEPAM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, DICLOFENAC, DICLOFENAC SODIUM, SEMAGLUTIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, SEMAGLUTIDE, |
||||
8 | 25494709 |
US |
1 | |
Influenza, Malaise, Product dose omission issue, |
||||
MITAPIVAT, |
||||
9 | 25494827 |
81 | 2 | |
Influenza, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
10 | 25494954 |
US |
||
Influenza, |
||||
VISMODEGIB, |
||||
11 | 25495160 |
CO |
72 | 2 |
Muscle spasms, Blood pressure decreased, Pneumonia, Choking, Condition aggravated, Discomfort, Cough, Nasopharyngitis, Influenza, Chest discomfort, Oropharyngeal discomfort, Oropharyngeal pain, Feeling abnormal, Dyspnoea, Decreased immune responsiveness, Malaise, Pain in extremity, Blood pressure increased, Weight decreased, Malaise, Product supply issue, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE, VALSARTAN, VALSARTAN ORAL, LETROZOLE, LETROZOLE TABLETS, DAPAGLIFLOZIN, |
||||
12 | 25495845 |
US |
47 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
13 | 25496154 |
US |
24 | 2 |
Nausea, Chest pain, Influenza, Headache, Myalgia, Pyrexia, Fatigue, Dizziness, |
||||
LEVONORGESTREL, |
||||
14 | 25496171 |
CA |
78 | 2 |
Abdominal discomfort, Hypertension, Influenza, Pruritus, Rash, Rash erythematous, Swollen joint count, Urticaria, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, METHYLPREDNISOLONE, PREDNISONE, |
||||
15 | 25496178 |
|||
Dermatitis atopic, Influenza, |
||||
RUXOLITINIB, |
||||
16 | 25496678 |
DE |
47 | 2 |
Myocarditis, Asthma, Influenza, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
17 | 25491359 |
US |
50 | 2 |
Influenza, Cough, |
||||
DUPILUMAB, DUPILUMAB, |
||||
18 | 25491377 |
CA |
55 | 2 |
Rash, Decreased activity, Dysstasia, Gait disturbance, General physical health deterioration, Grip strength decreased, Illness, Inappropriate schedule of product administration, Influenza, Pain, Psoriatic arthropathy, Treatment failure, Condition aggravated, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, HYDROCORTISONE, DESOXIMETASONE, ADALIMUMAB, HYDROXYCHLOROQUINE, INFLIXIMAB, MELOXICAM, MELOXICAM, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE SULFATE, TRAMADOL HYDROCHLORIDE, PREDNISONE, INFLIXIMAB, SULFASALAZINE, ADALIMUMAB-ADAZ, |
||||
19 | 25490923 |
US |
67 | 2 |
Negative thoughts, Bronchitis, Depression, Influenza, Blood pressure increased, Tremor, |
||||
DULOXETINE HYDROCHLORIDE, |
||||
20 | 25500028 |
54 | 2 | |
Pain, Arthralgia, Hypoaesthesia, Hypoaesthesia, Paraesthesia, Palpitations, Influenza, Hangover, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NIACIN, |
||||
21 | 25484655 |
65 | 2 | |
Nausea, Feeling of body temperature change, Pain, Asthma, Influenza, Dizziness, Back pain, Musculoskeletal stiffness, Blood glucose decreased, Fatigue, |
||||
TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, LEVOTHYROXINE SODIUM, FAMOTIDINE, CALCIUM CARBONATE, SIMETHICONE, CALCIUM CARBONATE, SODIUM CITRATE, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, BISMUTH SUBSALICYLATE, SEMAGLUTIDE, |
||||
22 | 25486662 |
CA |
||
Abdominal distension, Acne, Arthritis, Asthenia, Blood glucose increased, Concussion, Crohn^s disease, Diabetic neuropathy, Ear pain, Feeling abnormal, Frequent bowel movements, Muscle rupture, Pain in extremity, Rhinorrhoea, Sciatica, Vaginal discharge, Weight fluctuation, Abdominal pain, Arthralgia, Constipation, Fatigue, Headache, Influenza, Muscle spasms, Omphalitis, Weight decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SEMAGLUTIDE, CELECOXIB, DEXLANSOPRAZOLE, FLUCONAZOLE, FOLIC ACID, EMPAGLIFLOZIN, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, ROSUVASTATIN, |
||||
23 | 25486835 |
GB |
57 | 2 |
Hypokinesia, Anaemia, Pain, Poor quality sleep, Weight decreased, Dyspnoea, Malaise, Hot flush, Urticaria, Rash, Influenza, |
||||
VEDOLIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, |
||||
24 | 25486889 |
CL |
||
Enterococcal infection, Clostridium difficile infection, Gastroenteritis norovirus, Gastroenteritis rotavirus, Respiratory syncytial virus infection, Gastroenteritis Escherichia coli, Mycoplasma infection, Escherichia infection, Klebsiella infection, Gastroenteritis adenovirus, Tuberculosis, Bacterial infection, Influenza, Systemic infection, Metapneumovirus infection, Osteomyelitis, Lower respiratory tract infection, Hepatitis B reactivation, Gastrointestinal infection, Upper respiratory tract infection, Genitourinary tract infection, Staphylococcal infection, Skin infection, Varicella, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETANERCEPT, |
||||
25 | 25486924 |
CA |
12 | 1 |
Insulin-like growth factor increased, Pyrexia, Tremor, Stress, Hepatotoxicity, Nausea, Needle issue, Eye movement disorder, Agitation, Product use issue, Diarrhoea, Fall, Treatment failure, Brain injury, Hepatic enzyme increased, Helicobacter infection, Strabismus, Infrequent bowel movements, Vomiting, Chest pain, Gastric hypomotility, Injection site pain, Contusion, Seizure, Shunt occlusion, Swelling, Obsessive-compulsive disorder, Breath odour, Blood growth hormone increased, Gait disturbance, Cough, Viral diarrhoea, Neoplasm progression, Injection site haemorrhage, Eructation, Foot deformity, Influenza, Shunt malfunction, Device malfunction, Constipation, Growth hormone-producing pituitary tumour, Abdominal pain, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, MORPHINE SULFATE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, HYDROCORTISONE, HYDROCORTISONE, MELATONIN, PROPRANOLOL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, ATOMOXETINE HYDROCHLORIDE, CARBAMAZEPINE, ATOMOXETINE, ATOMOXETINE, TESTOSTERONE, TESTOSTERONE,, PRIMIDONE, PRIMIDONE, PRIMIDONE, PEGVISOMANT, RISPERIDONE, HYDROCORTISONE ACETATE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
26 | 25486951 |
CA |
||
Condition aggravated, COVID-19, Influenza, Illness, Immune system disorder, Sinusitis, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CELECOXIB, DEXLANSOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
27 | 25487200 |
US |
2 | |
Coma, Rib fracture, Pharyngitis streptococcal, Cough, Influenza, |
||||
ADALIMUMAB, |
||||
28 | 25487846 |
GB |
||
Hypokinesia, Anaemia, Poor quality sleep, Weight decreased, Hot flush, Malaise, Dyspnoea, Influenza, Pain, Urticaria, Rash, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, VEDOLIZUMAB, USTEKINUMAB, |
||||
29 | 25488773 |
US |
||
Influenza, Diplopia, Balance disorder, |
||||
30 | 25489273 |
US |
53 | 2 |
Influenza, Ear infection, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ATOGEPANT, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, MONTELUKAST SODIUM, MONTELUKAST, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
31 | 25490773 |
CA |
2 | |
Angina pectoris, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Gangrene, Hemiparesis, Hemiplegia, Influenza, Pneumonia, Rheumatoid arthritis, Product use issue, |
||||
IRBESARTAN, IRBESARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RAMIPRIL, AMLODIPINE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, CANDESARTAN, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PROCHLORPERAZINE, |
||||
32 | 25493389 |
2 | ||
Influenza, |
||||
LENALIDOMIDE, |
||||
33 | 25481506 |
US |
53 | 2 |
Pneumonia, Sensitive skin, Headache, Palmar-plantar erythrodysaesthesia syndrome, Hyperkeratosis, Hyperhidrosis, Migraine, Cough, Nasal congestion, Pain, Burning sensation, Paraesthesia, Oral mucosal blistering, Abdominal pain upper, Abdominal discomfort, Dysphonia, Fatigue, Oral pain, Pain in extremity, Blood pressure increased, Asthenia, Influenza, Pharyngitis, Nasopharyngitis, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, LORAZEPAM, CANNABIDIOL, ERGOCALCIFEROL, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LORAZEPAM, PROCHLORPERAZINE, PANTOPRAZOLE SODIUM, TURMERIC, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, AMOXICILLIN, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, AMLODIPINE BESYLATE, LANSOPRAZOLE, PROCHLORPERAZINE MALEATE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
34 | 25481680 |
GB |
||
Hypokinesia, Anaemia, Poor quality sleep, Hot flush, Malaise, Influenza, Pain, Dyspnoea, Weight decreased, Urticaria, Rash, Pruritus, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, VEDOLIZUMAB, |
||||
35 | 25482157 |
GB |
||
Conjunctivitis viral, Anal fissure, Decreased immune responsiveness, Fatigue, Hyperhidrosis, Influenza, |
||||
ADALIMUMAB-AATY, |
||||
36 | 25482220 |
CA |
37 | 2 |
Illness, Influenza, Ear infection, Pneumonia, |
||||
ETANERCEPT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
37 | 25482359 |
CA |
55 | 2 |
Choking, Malaise, Dyspnoea, Migraine, Dyspepsia, Weight increased, Alopecia, Dizziness, Ear disorder, Vertigo, Vomiting, Productive cough, Weight decreased, Asthma, Fatigue, Asthenia, Throat tightness, Pain in extremity, Secretion discharge, Influenza, Headache, Nasal congestion, Cough, Infection, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, UMECLIDINIUM, |
||||
38 | 25482634 |
US |
2 | |
Pneumonia, Influenza, Norovirus infection, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
39 | 25483096 |
US |
2 | |
Influenza, Conjunctivitis, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
40 | 25483360 |
GB |
57 | 2 |
Hypokinesia, Anaemia, Influenza, Malaise, Pain, Poor quality sleep, Dyspnoea, Hot flush, Weight decreased, Urticaria, Rash, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, VEDOLIZUMAB, |
||||
41 | 25483537 |
CA |
66 | 2 |
Product prescribing error, Drug ineffective, Influenza, Wrong technique in product usage process, SARS-CoV-2 test positive, Off label use, Platelet count decreased, COVID-19, Mouth haemorrhage, Platelet count increased, Fatigue, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RITUXIMAB, |
||||
42 | 25485246 |
US |
75 | |
Renal failure, Glycosylated haemoglobin increased, Influenza, Vomiting, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
43 | 25485413 |
CA |
36 | 2 |
Ankylosing spondylitis, Fatigue, Speech disorder, Migraine, Arthralgia, Exposure to fungus, Influenza, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, NIFEDIPINE, CELECOXIB, |
||||
44 | 25485431 |
CA |
53 | 1 |
Haematological infection, Illness, Influenza, Pneumonia, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
45 | 25485669 |
US |
||
Influenza, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, |
||||
46 | 25485826 |
US |
||
Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
47 | 25485898 |
US |
||
Influenza, Malaise, Inappropriate schedule of product administration, Product administration error, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
48 | 25486092 |
US |
||
Dyspnoea, Dizziness, Pyrexia, Diarrhoea, Abdominal pain upper, Abdominal discomfort, Hypersensitivity, Fall, Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
49 | 25476322 |
US |
65 | 2 |
Pneumonia, Influenza, |
||||
SEMAGLUTIDE, |
||||
50 | 25476452 |
TR |
52 | 2 |
Acute respiratory distress syndrome, Cytomegalovirus infection, Influenza, Pneumonia escherichia, Aspergillus infection, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
51 | 25476599 |
US |
78 | 2 |
Incorrect dose administered, Influenza, Dysphonia, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
52 | 25476626 |
CA |
61 | 1 |
Thrombosis, Pneumonia, Cytomegalovirus infection, COVID-19, Influenza, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
53 | 25477041 |
EG |
61 | 2 |
Influenza, Pyrexia, Off label use, Cardiomyopathy, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, |
||||
54 | 25477803 |
US |
2 | |
Influenza, Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
55 | 25477827 |
GB |
2 | |
Multiple sclerosis, Abdominal discomfort, Constipation, Haemorrhoids, Fatigue, Influenza, COVID-19, Band sensation, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
56 | 25477837 |
CO |
9 | 1 |
Influenza, |
||||
PALIVIZUMAB, |
||||
57 | 25478977 |
US |
22 | 1 |
Condition aggravated, Influenza, |
||||
ABROCITINIB, ABROCITINIB, |
||||
58 | 25479026 |
DE |
2 | |
Influenza, Dyspnoea, Cough, Nausea, Vomiting, Pyrexia, Hypotonia, Illness, |
||||
DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, NITROGLYCERIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, ALBUTEROL, UPADACITINIB, USTEKINUMAB, GUSELKUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
59 | 25479459 |
CO |
4 | 2 |
Influenza, Vomiting, |
||||
PALIVIZUMAB, |
||||
60 | 25479765 |
US |
46 | 1 |
Influenza, |
||||
DUPILUMAB, DUPILUMAB, |
||||
61 | 25480251 |
US |
37 | |
Nasopharyngitis, Influenza, Muscle spasms, Dizziness, Sluggishness, |
||||
DULAGLUTIDE, |
||||
62 | 25480480 |
US |
||
Influenza, Product dose omission issue, |
||||
MONOMETHYL FUMARATE, |
||||
63 | 25480592 |
US |
||
Influenza, |
||||
MONOMETHYL FUMARATE, |
||||
64 | 25481011 |
US |
62 | 2 |
Influenza, |
||||
LENALIDOMIDE, |
||||
65 | 25471670 |
CA |
12 | 1 |
Agitation, Brain injury, Breath odour, Chest pain, Constipation, Contusion, Cough, Device malfunction, Abdominal pain, Diarrhoea, Eructation, Eye movement disorder, Shunt occlusion, Fall, Blood growth hormone increased, Foot deformity, Gait disturbance, Gastric hypomotility, Growth hormone-producing pituitary tumour, Helicobacter infection, Hepatic enzyme increased, Hepatotoxicity, Influenza, Infrequent bowel movements, Injection site haemorrhage, Injection site pain, Insulin-like growth factor increased, Nausea, Needle issue, Neoplasm progression, Obsessive-compulsive disorder, Product use issue, Pyrexia, Seizure, Shunt malfunction, Strabismus, Stress, Swelling, Treatment failure, Tremor, Viral diarrhoea, Vomiting, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, RISPERIDONE, SERTRALINE HYDROCHLORIDE, PEGVISOMANT, PEGVISOMANT, PEGVISOMANT, ATOMOXETINE, CARBAMAZEPINE, HYDROCORTISONE, HYDROCORTISONE, MELATONIN, MORPHINE SULFATE, PEGVISOMANT, PRIMIDONE, PRIMIDONE, PRIMIDONE, ATOMOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, TESTOSTERONE, TESTOSTERONE,, |
||||
66 | 25472240 |
US |
1 | |
Influenza, |
||||
67 | 25473176 |
US |
10 | 1 |
Thrombocytopenia, Influenza, |
||||
GIVINOSTAT, PREDNISONE, ERGOCALCIFEROL, LISINOPRIL, |
||||
68 | 25475123 |
CA |
56 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Full blood count abnormal, Influenza, Loss of personal independence in daily activities, Nasopharyngitis, Wheezing, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
69 | 25475224 |
PT |
59 | 2 |
Haematotoxicity, Neutropenia, Influenza, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, VENETOCLAX, VENETOCLAX, |
||||
70 | 25475347 |
SI |
52 | 1 |
Weight decreased, Gastrooesophageal reflux disease, Gastric polyps, Cytogenetic analysis abnormal, Drug ineffective, Acute myocardial infarction, Pain, Blood cholesterol increased, Influenza, Otitis media, |
||||
IMATINIB, NILOTINIB, |
||||
71 | 25475531 |
US |
68 | 1 |
Influenza, Pneumonia, |
||||
72 | 25475534 |
US |
2 | |
Nasopharyngitis, Influenza, Injection site bruising, Injection site haemorrhage, |
||||
73 | 25475846 |
US |
80 | 2 |
COVID-19, Influenza, Dyspnoea, Lung disorder, |
||||
IBRUTINIB, IBRUTINIB, |
||||
74 | 25478871 |
38 | 2 | |
COVID-19, Influenza, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
75 | 25465502 |
57 | 2 | |
Illness, Pyrexia, Nausea, Dyspnoea, Chest pain, Influenza, Bedridden, Product dose omission issue, |
||||
ADALIMUMAB-RYVK, |
||||
76 | 25465505 |
ES |
89 | 1 |
Influenza, Acute respiratory failure, Metabolic acidosis, |
||||
OXALIPLATIN, PEMBROLIZUMAB, CAPECITABINE, |
||||
77 | 25465801 |
AU |
60 | |
Hypoglycaemia, Hyperglycaemia, Nasopharyngitis, Influenza, Hypoglycaemia, Hyperglycaemia, Wrong technique in product usage process, |
||||
ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, |
||||
78 | 25466042 |
BR |
70 | 2 |
Rheumatoid arthritis, Hypoacusis, Eating disorder, Influenza, Drug ineffective, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
79 | 25466048 |
US |
76 | 1 |
Influenza, Immunodeficiency, COVID-19, Bacterial infection, Idiopathic pulmonary fibrosis, |
||||
NINTEDANIB, NINTEDANIB, |
||||
80 | 25466122 |
US |
47 | 2 |
Influenza, |
||||
NATALIZUMAB, |
||||
81 | 25466247 |
BR |
2 | |
Influenza, Respiratory disorder, Cough, Weight increased, Asthma, Weight decreased, |
||||
PALIVIZUMAB, PALIVIZUMAB, PALIVIZUMAB, BECLOMETHASONE DIPROPIONATE, FERROUS SULFATE, |
||||
82 | 25466805 |
GB |
57 | 2 |
Hypokinesia, Anaemia, Malaise, Pain, Hot flush, Weight decreased, Poor quality sleep, Urticaria, Rash, Influenza, Dyspnoea, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, VEDOLIZUMAB, |
||||
83 | 25467092 |
BR |
1 | |
Bronchiolitis, Influenza, Fatigue, Therapy cessation, |
||||
PALIVIZUMAB, |
||||
84 | 25467976 |
CA |
2 | |
Frequent bowel movements, Cholestasis, Hyperhidrosis, Hepatic fibrosis, Myalgia, Dyspepsia, Tendon pain, Influenza, Conjunctivitis, Skin odour abnormal, Bone density decreased, Dry eye, Progressive massive fibrosis, Vasoconstriction, Asthenia, Sleep disorder, Alopecia, Faeces hard, Pollakiuria, Dehydration, Feeling abnormal, Raynaud^s phenomenon, Peripheral swelling, Abdominal discomfort, Liver function test abnormal, Increased liver stiffness, Abdominal pain, Palpitations, Rash macular, Arthralgia, Pruritus, Alanine aminotransferase abnormal, Blood alkaline phosphatase abnormal, Aspartate aminotransferase abnormal, Drug effect less than expected, Skin discolouration, Diarrhoea, Photosensitivity reaction, Osteopenia, Insomnia, Dry mouth, |
||||
OBETICHOLIC ACID, |
||||
85 | 25468196 |
GB |
35 | 1 |
Influenza, Neutrophil count decreased, White blood cell count decreased, |
||||
CLOZAPINE, |
||||
86 | 25468627 |
US |
45 | 2 |
Vomiting, Influenza, Decreased appetite, Pain, |
||||
AXITINIB, |
||||
87 | 25468650 |
US |
88 | 2 |
Bronchitis, Influenza, Visual impairment, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
88 | 25469550 |
CA |
2 | |
Pericarditis, Influenza, Product dose omission issue, |
||||
BIMEKIZUMAB, TELMISARTAN, DEXLANSOPRAZOLE, CELECOXIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SEMAGLUTIDE, |
||||
89 | 25469562 |
CA |
77 | 2 |
Fatigue, Gait disturbance, Hypersensitivity, Hypotension, Influenza, Labyrinthitis, Left ventricular outflow tract gradient increased, Lymphadenopathy, Migraine, Nausea, Abdominal pain upper, Off label use, Axillary pain, Blood pressure systolic increased, COVID-19, Cough, Decreased activity, Dizziness, Dyspnoea, |
||||
CANDESARTAN CILEXETIL, ERGOCALCIFEROL, MAVACAMTEN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, PROPRANOLOL HYDROCHLORIDE, |
||||
90 | 25465180 |
US |
72 | 2 |
Confusional state, Infusion site urticaria, Bronchitis, Dysphoria, Allergy to immunoglobulin therapy, Brain fog, Somnolence, Infusion site discharge, Influenza, Cough, Infusion site bruising, Infusion site haemorrhage, Chills, Fatigue, Headache, Dyspnoea, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, MORPHINE SULFATE, PREDNISONE, DENOSUMAB, NIFEDIPINE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, CICLESONIDE, CHLORTHALIDONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, EPINEPHRINE, ADRENALINUM, AMLODIPINE BESYLATE, PRAVASTATIN SODIUM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, NALOXEGOL OXALATE, |
||||
91 | 25464017 |
ES |
89 | 1 |
Influenza, Acute respiratory failure, Metabolic acidosis, |
||||
OXALIPLATIN, PEMBROLIZUMAB, CAPECITABINE, |
||||
92 | 25458112 |
CO |
46 | 2 |
Paralysis, Sleep apnoea syndrome, Discouragement, Pain, Influenza, |
||||
METRELEPTIN, |
||||
93 | 25458223 |
24 | 1 | |
Sickle cell anaemia with crisis, Influenza, |
||||
GLUTAMINE, L-GLUTAMINE, |
||||
94 | 25458311 |
51 | 1 | |
Illness, Influenza, Product dose omission issue, |
||||
GLUTAMINE, |
||||
95 | 25458318 |
14 | 2 | |
Sickle cell anaemia with crisis, Influenza, Product dose omission issue, |
||||
GLUTAMINE, |
||||
96 | 25458696 |
US |
1 | |
Influenza, Sleep disorder, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
97 | 25459094 |
US |
64 | 2 |
Influenza, Pain, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, EZETIMIBE, FAMOTIDINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MONTELUKAST, PANTOPRAZOLE, PREDNISONE, ROSUVASTATIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ICOSAPENT ETHYL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
98 | 25459176 |
US |
41 | 1 |
Bronchitis, Upper respiratory tract infection, Influenza, Pharyngitis streptococcal, Epiglottitis, |
||||
RISANKIZUMAB-RZAA, |
||||
99 | 25459179 |
ES |
||
Fungal infection, Viral infection, Bacterial infection, Clostridium difficile infection, Pseudomonal bacteraemia, Mucormycosis, Aspergillus infection, Systemic candida, COVID-19, Influenza, Staphylococcal bacteraemia, Escherichia bacteraemia, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
100 | 25459310 |
GB |
57 | 2 |
Hypokinesia, Anaemia, Pain, Poor quality sleep, Hot flush, Weight decreased, Malaise, Rash, Urticaria, Influenza, Dyspnoea, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, VEDOLIZUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29